Poly Cystic Ovarian Syndrome (PCOS): A review

Swetchha Padwal

Abstract


Polycystic ovarian syndrome is one of the predominant reasons responsible for infertility among women. PCOS affects 1 in every 10 women of fertile age. Women with PCOS have severe hormonal imbalances and this affects their overall appearances. The symptoms of Polycystic ovary include excess hair growth, acne, obesity, acanthosis nigricans, and irregular menses.

There is no cure currently available for PCOS as the genetic cause is yet unknown, but the symptoms can be treated using hormonal therapies such as clomiphene citrate and metformin. In extreme cases, surgery (laparoscopic ovarian drilling) is used for women with PCOS to give them a chance at motherhood. The hormonal therapies help to normalize the symptoms and have been an effective treatment strategy over the years.

References


Azziz, R., & Adashi, E. Y. (2016). Stein and Leventhal: 80 years on. American journal of obstetrics and gynecology, 214(2), 247-e1.

Nidhi, R., Padmalatha, V., Nagarathna, R., & Amritanshu, R. (2011). Prevalence of polycystic ovarian syndrome in Indian adolescents. Journal of pediatric and adolescent gynecology, 24(4), 223-227.

Lakhani, K., Seifalian, A. M., Atiomo, W. U., & Hardiman, P. (2002). Polycystic ovaries. The British Journal of Radiology, 75(889), 9-16.

Hopkinson, Z. E., Sattar, N., Fleming, R., & Greer, I. A. (1998). Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. Bmj, 317(7154), 329-332.

Nestler, J. E. (1997). Insulin regulation of human ovarian androgens. Human Reproduction, 12(suppl_1), 53-62.

Carey, A. H., Chan, K. L., Short, F., White, D., Williamson, R., & Franks, S. (1993). Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clinical endocrinology, 38(6), 653-658.

Ndefo, U. A., Eaton, A., & Green, M. R. (2013). Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P & T : a peer-reviewed journal for formulary management, 38(6), 336–355.

Balen, A. H., Conway, G. S., Kaltsas, G., Techatrasak, K., Manning, P. J., West, C., & Jacobs, H. S. (1995). Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human reproduction (Oxford, England), 10(8), 2107–2111.

Webber, L. J., Stubbs, S., Stark, J., Trew, G. H., Margara, R., Hardy, K., & Franks, S. (2003). Formation and early development of follicles in the polycystic ovary. The Lancet, 362(9389), 1017-1021.

Davidson, M. B. (2005). Insulin resistance and the polycystic ovary syndrome. FAMILY PRACTICE RECERTIFICATION, 27(11), 72.

Raperport, C., & Homburg, R. (2019). The source of polycystic ovarian syndrome. Clinical Medicine Insights: Reproductive Health, 13, 1179558119871467.

GOLDZIEHER, J. W., & Green, J. A. (1962). The polycystic ovary. I. Clinical and histologic features. The Journal of Clinical Endocrinology & Metabolism, 22(3), 325-338.

Norman, R. J., & Moran, L. J. (2007). Diet and Lifestyle Factors in the Etiology and Management of Polycystic Ovary Syndrome. In Insulin Resistance and Polycystic Ovarian Syndrome (pp. 147-162). Humana Press.

Hart, R., Hickey, M., & Franks, S. (2004). Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology, 18(5), 671-683.

Teknetzis, A., Lefaki, I., Joannides, D., & Minas, A. (1993). Acanthosis nigricans-like lesions after local application of fusidic acid. Journal of the American Academy of Dermatology, 28(3), 501–502. https://doi.org/10.1016/s0190-9622(08)81767-7

Battaglia, C., De Iaco, P., Iughetti, L., Mancini, F., Persico, N., Genazzani, A. D., & De Aloysio, D. (2005). Female precocious puberty, obesity and polycystic‐like ovaries. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 26(6), 651-657.

Kaur, P. (2017). Polycystic Ovary Syndrome (PCOS): an under-recognized cardiovascular risk factor in women (Doctoral dissertation, Fresno Pacific University).

Legro, R. S., Kunselman, A. R., Dodson, W. C., & Dunaif, A. (1999). Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. The Journal of clinical endocrinology and metabolism, 84(1), 165–169.

Norman, R. J., & Moran, L. J. (2007). Diet and Lifestyle Factors in the Etiology and Management of Polycystic Ovary Syndrome. In Insulin Resistance and Polycystic Ovarian Syndrome (pp. 147-162). Humana Press.

Norman, R. J., Davies, M. J., Lord, J., & Moran, L. J. (2002). The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology & Metabolism, 13(6), 251-257.Teknetzis, A., Lefaki, I., Joannides, D., & Minas, A. (1993). Acanthosis nigricans-like lesions after local application of fusidic acid. Journal of the American Academy of Dermatology, 28(3), 501–502. https://doi.org/10.1016/s0190-9622(08)81767-7

Carmina, E., Koyama, T., Chang, L., Stanczyk, F. Z., & Lobo, R. A. (1992). Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?. American journal of obstetrics and gynecology, 167(6), 1807–1812. https://doi.org/10.1016/0002-9378(92)91779-a

Miranda, B. H., Charlesworth, M. R., Tobin, D. J., Sharpe, D. T., & Randall, V. A. (2018). Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life. The FASEB Journal, 32(2), 795-806.

FRANKS, S. (1989). Polycystic ovary syndrome: a changing perspective. Clinical endocrinology, 31(1), 87-120.

Slayden, S. M., Moran, C., Sams Jr, W. M., Boots, L. R., & Azziz, R. (2001). Hyperandrogenemia in patients presenting with acne. Fertility and sterility, 75(5), 889-892.

Hopkinson, Z. E., Sattar, N., Fleming, R., & Greer, I. A. (1998). Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. Bmj, 317(7154), 329-332.

Frempong, B. A., Ricks, M., Sen, S., & Sumner, A. E. (2008). Effect of low-dose oral contraceptives on metabolic risk factors in African-American women. The Journal of Clinical Endocrinology & Metabolism, 93(6), 2097-2103.

Hopkinson, Z. E., Sattar, N., Fleming, R., & Greer, I. A. (1998). Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. Bmj, 317(7154), 329-332.

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. (1998). Bmj Journals, 317–329. https://doi.org/10.1136/bmj.317.7154.329

Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1995). Ovarian Tumors in a Cohort of Infertile Women. Obstetrical & Gynecological Survey, 50(2), 125-128.

Homburg R. (2008). Polycystic ovary syndrome. Best practice & research. Clinical obstetrics & gynaecology, 22(2), 261–274. https://doi.org/10.1016/j.bpobgyn.2007.07.009

Glueck, C. J., Goldenberg, N., Pranikoff, J., Loftspring, M., Sieve, L., & Wang, P. (2004). Height, weight, and motor–social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Human Reproduction, 19(6), 1323-1330.

Keckstein J. (1989). Laparoscopic treatment of polycystic ovarian syndrome. Bailliere's clinical obstetrics and gynaecology, 3(3), 563–581. https://doi.org/10.1016/s0950-3552(89)80009-4

AAKVAAG, A., & GJØNNÆSS, H. (1985). Hormonal response to electrocautery of the ovary in patients with polycystic ovarian disease. BJOG: An International Journal of Obstetrics & Gynaecology, 92(12), 1258-1264.

Greenblatt, E., & Casper, R. F. (1987). Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome. American journal of obstetrics and gynecology, 156(2), 279–285. https://doi.org/10.1016/0002-9378(87)90268-7

R.S.L.M.D. (2017). Evaluation and Treatment of Polycystic Ovary Syndrome. https://www.ncbi.nlm.nih.gov/books/NBK278959/


Refbacks

  • There are currently no refbacks.


Published by:

 Indian Science and Technology Foundation (ISTF)

 C-1/31, Yamuna Vihar, New Delhi-110053 

Email: contact@isto-india.org

www.isto-india.org